Physician profile

Darryn L Appleton

Interventional Cardiology · Richmond, VA

NPI 1740497007

$6,622.01

in general payments reported to CMS, 2019-2025

44 companies · $824 in 2025

The $824 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,256.87
Education$20.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $1,483.87 2019-2020
Abbott Laboratories $819.39 2019-2025 Dragonfly Opstar, Coroflow, Thoratec Heartmate 3 Lvas Implant Kit
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $433.31 2019-2025 Lifevest
Novartis Pharmaceuticals Corporation $414.87 2021-2025
Medtronic Vascular, INC. $352.11 2019-2020
Arineta, INC $326.39 2024 Spotlight
Abiomed $312.39 2019-2024 Impella
Heartflow, INC. $206.59 2019-2025
Pfizer INC. $203.55 2019-2024
Medtronic, INC. $201.26 2021-2025 Signia, Corevalve Evolut R, Ffrangio
Boston Scientific Corporation $167.84 2021-2023 Watchman Flx
Atricure, INC. $145.97 2019-2021
Novo Nordisk INC $127.10 2023-2024 Ozempic, Rybelsus, Wegovy
Boehringer Ingelheim Pharmaceuticals, INC. $122.86 2020-2025 Jardiance
Amgen INC. $120.21 2023-2025 Repatha
Show all 44 companies
CompanyGeneral paymentsYearsTop products
Scpharmaceuticals INC. $114.53 2023-2025
Alnylam Pharmaceuticals INC. $102.06 2023-2025 Onpattro
Janssen Pharmaceuticals, INC $90.98 2020-2024 Xarelto
E.R. Squibb & Sons, L.L.C. $84.63 2022-2025 Camzyos, Eliquis
Silk Road Medical, INC. $81.27 2020
Cleerly, INC. $67.79 2025 Cleerly Ischemia, Cleerly Labs
Bayer Healthcare Pharmaceuticals INC. $56.47 2025
Astrazeneca Pharmaceuticals LP $54.01 2021-2024 Lokelma
Cardiovascular Systems INC. $51.08 2022
Penumbra, INC. $44.02 2019-2025 Indigo System
Lexicon Pharmaceuticals, INC. $43.33 2023-2024 Inpefa
Sanofi-Aventis U.S. LLC $40.32 2021-2022
Kestra Medical Technology Services, INC. $31.79 2025 Assure Wcd
Lemaitre Vascular, INC. $30.77 2022
Daiichi Sankyo INC. $28.74 2023 Injectafer
Gilead Sciences, INC. $24.90 2019
Angiodynamics, INC. $22.23 2023 Alphavac
Regeneron Healthcare Solutions, INC. $21.56 2025 Evkeeza
Bard Peripheral Vascular, INC. $21.53 2023 Presto
Irhythm Technologies, INC. $21.50 2019
Contego Medical, INC $19.68 2023
Cvrx, INC. $19.18 2024 Barostim Neo System
Merck Sharp & Dohme LLC $18.99 2021
Esperion Therapeutics, INC. $18.53 2022
Livanova USA, INC. $16.93 2020
Actelion Pharmaceuticals US, INC. $16.73 2024 Opsumit, Uptravi
Medicomp INC $15.90 2022
Amarin Pharma, INC. $13.59 2019
Aegerion Pharmaceuticals, INC. $11.26 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Darryn L Appleton

$6,622.01

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $824 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/79659/darryn-l-appleton

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.